Forbion Co-leads $70 Million Financing of F2G to Advance Development and Commercialization of New Antifungal Agent Olorofim

Press release content from Globe Newswire. The AP news staff was not involved in its creation.

Related Keywords

Germany ,Austria ,Netherlands ,United Kingdom ,Singapore ,Naarden ,Noord Holland ,Dutch ,Laura Asbjornsen ,Ashley Tapp ,Joe Anderson ,Francesco Maria Lavino ,Sue Charles ,Head Of Communications ,Forbion Growth Opportunities Fund ,European Recovery Programme ,Drug Administration ,Cg Ltd ,European Medicines Agency ,Dutch Venture Initiative ,Consilium Strategic Communications ,Forbion Co Leads ,Advance Development ,New Antifungal Agent ,Sofinnova Partners ,General Partner ,Breakthrough Therapy Designation ,New Drug Application ,Maria Lavino ,Chief Executive Officer ,United Nations Principles ,Kfw Capital ,Venture Capital Fonds ,Qualified Infectious Disease Product ,Health ,Business ,Europe ,Venture Capital ,Climate And Environment ,Globe Newswire ,